HCPCS Level II · Drugs administered other than oral method
J2182Injection, mepolizumab, 1 mg
✓ Active
Source: CMS HCPCS quarterly update, October 2026. Page updated September 29, 2026.
About J2182
J2182 is an HCPCS Level II code in the J series (drugs administered other than oral method), describing injection, mepolizumab, 1 mg.
It was added to HCPCS effective 01/01/2017.
Its Medicare coverage code is "C", meaning coverage is left to the Medicare contractor's judgment.
Details
- Short description
- Injection, mepolizumab, 1mg
- Date added
- 01/01/2017
- Action effective
- 01/01/2017
- BETOS
- O1E
Related J21xx codes
- J2151Injection, mannitol, 250 mg
- J2170Injection, mecasermin, 1 mg
- J2175Injection, meperidine hydrochloride, per 100 mg
- J2180Injection, meperidine and promethazine hcl, up to 50 mg
- J2183Injection, meropenem (wg critical care), not therapeutically equivalent to j2185, 100 mg
- J2184Injection, meropenem (b. braun), not therapeutically equivalent to j2185, 100 mg
- J2185Injection, meropenem, 100 mg
- J2186Injection, meropenem and vaborbactam, 10mg/10mg (20mg)
Common questions about J2182
Is HCPCS J2182 still valid?
- Yes. J2182 is active in the CMS October 2026 HCPCS file.
Does Medicare cover J2182?
- Its coverage code is "C": coverage is left to the Medicare contractor's judgment. Check the local coverage determination for your region.